Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Health
By Stephanie Nolen from NYT Health https://ift.tt/dITgQOk
via IFTTT Acquired Immune Deficiency Syndrome, Medicine and Health, Prices (Fares, Fees and Rates), Generic Brands and Products, Drugs (Pharmaceuticals), Developing Countries, Intellectual Property, Inventions and Patents, Epidemics Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.

Comments

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women